Label: SWIFTALYN FUNGAL NAIL TREATMENT- fungal nail treatment liquid

  • NDC Code(s): 84048-002-01
  • Packager: Shenzhen Peruidaishi Technology Co., Ltd.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated January 25, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    Miconazole nitrate 2%

  • Purpose

    This product provides relief from nailthickening yellow-brown discoloration.brittleness,crumbliness, shape distortiondark color caused by debris build-upunder thenail or unpleasant odor.

  • Use


    Apply once in the moring and once inthe evening, Ensure nails arethoroughlycleansed and dry.cently file and trimnailsto enhance the absorption andeffectiveness of the product.

  • Warnings

    Donotusethe product on children under10years of age unlass directed by a doctor.*Avoid contact with the eyes.if contact occursrinse thoroughly with waterand seek medicaladvica.
    . Ahvays perform a s kin patch test bafore usingthe product.lf irritation occurs discontinue use..Kaep the product out of reach ofchildren.for axtemal use only. if swvallowed, saekimmediate medical assistanca

  • Do not use

    Ahays perform a skin patch test before using the product.lf iritation occurs discontinue use.

  • When Using

    Repeat this process daily until the fungalinfections has completely healed. for optimaloutcomes,continue applying the treatmant foran additional 7days after the symptoms havesubsided

  • Stop Use

    May be harmful if used when pregnant or breast-feeding
    Keep Out Of Reach Of Chlidren: if swallowed,get medical help or contact a Poison Control Center right away.

  • Keep Oot Of Reach Of Children

    Keep Out Of Reach Of Chlidren

  • Directions

    lmmerse your feat in hot water for 10 minutesand ensure your nails are completely dry.. Utilize a nail clipper or file to eliminate as muchof the affected nails as you can..Apply an appropriate quantity of the fungalnail treatment solution to the infected nailsand let them dry.
    . Repeat this process daily until the fungalinfections hascompletety healed.for optimaloutcomes,continue applying the treatment foran additional 7days after the symptoms havesubsided
    .if the symptoms parsist evan after 40 days ofconsistent use, it is advisable to seok medicaladvice from a doctor

  • Other information

    Avoid direct sunlight. store at roomtemperature between15-30°C(59-86°F).

  • Inactive ingredients

    Water
    Sorbitol
    Alcohol
    Propylene Glycol
    Angelica Dahurica Root
    Laurocapram
    Caramel
    Dimethylol Urea
    FD&C Yellow No. 6

  • PRINCIPAL DISPLAY PANEL

    1

  • INGREDIENTS AND APPEARANCE
    SWIFTALYN FUNGAL NAIL TREATMENT 
    fungal nail treatment liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:84048-002
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    MICONAZOLE NITRATE (UNII: VW4H1CYW1K) (MICONAZOLE - UNII:7NNO0D7S5M) MICONAZOLE NITRATE2 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    SORBITOL (UNII: 506T60A25R)  
    ANGELICA DAHURICA ROOT (UNII: 1V63N2S972)  
    OXYMETHUREA (UNII: N68H97CAWG)  
    ALCOHOL (UNII: 3K9958V90M)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    LAUROCAPRAM (UNII: 1F3X9DRV9X)  
    CARAMEL (UNII: T9D99G2B1R)  
    WATER (UNII: 059QF0KO0R)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:84048-002-0130 mL in 1 BOTTLE; Type 0: Not a Combination Product01/24/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02901/24/2024
    Labeler - Shenzhen Peruidaishi Technology Co., Ltd. (706728459)
    Establishment
    NameAddressID/FEIBusiness Operations
    Shenzhen Peruidaishi Technology Co., Ltd.706728459label(84048-002) , manufacture(84048-002)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!